Annual report pursuant to Section 13 and 15(d)

Organization (Details Narrative)

v3.24.1
Organization (Details Narrative) - USD ($)
12 Months Ended
Jan. 30, 2024
Jan. 22, 2024
Dec. 31, 2023
Dec. 31, 2022
Jan. 21, 2024
Jun. 27, 2023
OrganizationLineItems [Line Items]            
Common stock, par value     $ 0.0001 $ 0.0001    
Common stock shares issued     1,291,000 806,774    
Common stock shares outstanding     1,286,000 801,774    
Common stock shares authorized     100,000,000 50,000,000   100,000,000
Accumulated deficit     $ 75,369,081 $ 64,247,561    
Net loss     11,121,520 27,424,229    
Net cash used in operating activities     8,063,346 9,605,143    
Net proceeds     6,321,470    
Cash and cash equivalents     $ 4,706,197 $ 6,503,595    
Subsequent Event [Member]            
OrganizationLineItems [Line Items]            
Reverse stock split   1-for-20 reverse stock split        
Common stock, par value   $ 0.0001        
Common stock shares issued   1,291,000     24,706,474  
Common stock shares outstanding   1,286,000     24,606,474  
Common stock shares authorized   100,000,000        
Number of shares, sold 476,000          
Net proceeds $ 6,300,000          
Subsequent Event [Member] | Pre-Funded Warrants [Member]            
OrganizationLineItems [Line Items]            
Warrants to purchase 1,079,555          
Warrants, exercised 1,079,555          
Subsequent Event [Member] | Warrant [Member]            
OrganizationLineItems [Line Items]            
Warrants to purchase 1,555,555